Biological Therapy Analysis & Statistics, March 2015 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

61-90 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Plerixafor  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Plerixafor - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Biological Therapy
Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering ...

  • Industries : Biological Therapy
Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Dermatology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering ...

  • Industries : Biological Therapy
Gene Therapy Genito Urinary System And Sex Hormones Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Genito Urinary System And Sex Hormones Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Genito Urinary System and Sex Hormones Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy ...

  • Industries : Biological Therapy
Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value ...

  • Industries : Biological Therapy
Physician Views: The FDA gives a thumbs-up to the first potential US biosimilar, but what do oncologists think?

Physician Views: The FDA gives a thumbs-up to the first potential US biosimilar, but what do oncologists think?

  • $ 615
  • Industry report
  • January 2015
  • by Firstword Pharma

Scope A significant step towards the realisation of biosimilar competition in the US market was taken last week when the FDA's Oncologic Drugs Advisory Committee (ODAC) voted unanimously to recommend approval ...

  • Industries : Biopharmaceutical, Biological Therapy, General Medicine and Specialty Medicine, Biotechnology, Therapy, Healthcare
Plerixafor  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Plerixafor - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Biological Therapy
Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

  • $ 412
  • Industry report
  • February 2015
  • by La Merie Publishing

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides ...

  • Industries : Biopharmaceutical
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops parthenogenesis, a stem cell technology that advances the field of regenerative medicine. It develops ...

  • Industries : Biological Therapy
Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company’s services include cell therapy. Its cell therapy is developing a novel cell-based therapy ...

  • Industries : Biological Therapy
U.S. Orthopedic Biomaterials Market - Executive Summary

U.S. Orthopedic Biomaterials Market - Executive Summary

  • $ 295
  • Industry report
  • January 2015
  • by iData Research, Inc.

The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential ...

  • Industries : Orthopedic, Biomaterial, Biomaterial, Medical Devices, Biotechnology, Advanced Material
  • Countries : United States
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2015
  • by Global Data

Summary Interleukin Genetics, Inc. (Interleukin) develops and distributes genetic tests for the personalized health market. It offers its products and services under the brands, Inherent Health and PerioPredict. ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2015
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
Bioheart, Inc. (BHRT) - Medical Equipment - Deals and Alliances Profile

Bioheart, Inc. (BHRT) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2015
  • by Global Data

Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focuses solely on providing cell technologies that aid in the treatment of cardiovascular and related diseases. Its product candidates ...

  • Industries : Biological Therapy
International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • March 2015
  • by Wright Investors' Service

A textual analysis of the financial results for International Stem Cell Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States, World
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
  • Countries : Japan
The Market for Personalized Gene Therapy Treatments for Cancer

The Market for Personalized Gene Therapy Treatments for Cancer

  • $ 3 995
  • Industry report
  • December 2014
  • by Kalorama Information

This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach in cancer research. It involves modification ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Biological Therapy, Pharmaceutical, Healthcare
  • Countries : United States, World
Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

  • $ 2 838
  • Industry report
  • December 2014
  • by La Merie Publishing

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants A Pipeline Landscape Analysis and Comparative ...

  • Industries : Pathology, Biopharmaceutical
  • Countries : United States
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
Global Regenerative Medicine Market 2015-2019

Global Regenerative Medicine Market 2015-2019

  • $ 2 500
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Regenerative Medicines Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine
  • Countries : World
Cellectis S.A. - Product Pipeline Review - 2014

Cellectis S.A. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Cellectis S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Cellectis S.A. - Product Pipeline Review - 2014’, provides an overview of the Cellectis S.A.’s pharmaceutical research ...

  • Industries : Research and Development, Pathology, Biopharmaceutical
  • Countries : World
Amarna Therapeutics B.V. - Product Pipeline Review - 2014

Amarna Therapeutics B.V. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Amarna Therapeutics B.V. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Amarna Therapeutics B.V. - Product Pipeline Review - 2014’, provides an overview of the Amarna Therapeutics ...

  • Industries : Therapy, Biopharmaceutical, Biological Therapy, Biotechnology, Pharmaceutical, Research and Development
  • Countries : Netherlands, World
Erytech Pharma SA - Product Pipeline Review - 2014

Erytech Pharma SA - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Erytech Pharma SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Erytech Pharma SA - Product Pipeline Review - 2014’, provides an overview of the Erytech Pharma SA’s pharmaceutical ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Research and Development, Pharmaceutical
  • Countries : South Africa, Saudi Arabia
NeoStem, Inc. - Product Pipeline Review - 2014

NeoStem, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

NeoStem, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘NeoStem, Inc. - Product Pipeline Review - 2014’, provides an overview of the NeoStem, Inc.’s pharmaceutical research ...

  • Industries : Biological Therapy, Pathology, Research and Development
  • Countries : United States
Immune Design Corp. - Product Pipeline Review - 2014

Immune Design Corp. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Immune Design Corp. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Research and Development
  • Countries : United States
Malignant Glioma - Pipeline Review, H2 2014

Malignant Glioma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Malignant Glioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Glioma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Retinal Degeneration - Pipeline Review, H2 2014

Retinal Degeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Retinal Degeneration - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Retinal Degeneration - Pipeline Review, H2 2014’, provides an overview of the Retinal Degeneration’s therapeutic ...

  • Industries : Pathology, Research and Development, Pharmaceutical
  • Countries : World, United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Bone Fracture - Pipeline Review, H2 2014

Bone Fracture - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Bone Fracture - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bone Fracture - Pipeline Review, H2 2014’, provides an overview of the Bone Fracture’s therapeutic pipeline. This report ...

  • Industries : Pharmaceutical, Biological Therapy
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.